In silico SARS-CoV-2 vaccine development for Omicron strain using reverse vaccinology

被引：0
|
作者：
Vladimir Li
Chul Lee
DongAhn Yoo
Seoae Cho
Heebal Kim
机构：
[1] Seoul National University,Interdisciplinary Program in Bioinformatics
[2] Seoul National University,Department of Agricultural Biotechnology, Research Institute for Agriculture and Life Sciences
[3] eGnome,undefined
来源：
Genes & Genomics | 2022年 / 44卷
关键词：
SARS-CoV-2; Omicron; Reverse vaccinology; Vaccine design;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：937 / 944
页数：7
相关论文
共 50 条
  • [41] In silico design of miniprotein to inhibit SARS-CoV-2 variant Omicron spike protein
    Wu, Jianhua
    Zhang, Hong-Xing
    Zhang, Jilong
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2023, 25 (21) : 14711 - 14725
  • [42] HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
    Fleury, Herve
    VIRUSES-BASEL, 2022, 14 (12):
  • [43] Development of an inactivated vaccine candidate for SARS-CoV-2
    Gao, Qiang
    Bao, Linlin
    Mao, Haiyan
    Wang, Lin
    Xu, Kangwei
    Yang, Minnan
    Li, Yajing
    Zhu, Ling
    Wang, Nan
    Lv, Zhe
    Gao, Hong
    Ge, Xiaoqin
    Kan, Biao
    Hu, Yaling
    Liu, Jiangning
    Cai, Fang
    Jiang, Deyu
    Yin, Yanhui
    Qin, Chengfeng
    Li, Jing
    Gong, Xuejie
    Lou, Xiuyu
    Shi, Wen
    Wu, Dongdong
    Zhang, Hengming
    Zhu, Lang
    Deng, Wei
    Li, Yurong
    Lu, Jinxing
    Li, Changgui
    Wang, Xiangxi
    Yin, Weidong
    Zhang, Yanjun
    Qin, Chuan
    SCIENCE, 2020, 369 (6499) : 77 - +
  • [44] SARS-CoV-2 vaccine candidates in rapid development
    Li, Lifeng
    Guo, Pengbo
    Zhang, Xiaoman
    Yu, Zhidan
    Zhang, Wancun
    Sun, Huiqing
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 644 - 653
  • [45] Platforms Exploited for SARS-CoV-2 Vaccine Development
    Mathew, Shilu
    Faheem, Muhammed
    Hassain, Neeraja A.
    Benslimane, Fatiha M.
    Al Thani, Asmaa A.
    Zaraket, Hassan
    Yassine, Hadi M.
    VACCINES, 2021, 9 (01) : 1 - 24
  • [46] Development of SARS-CoV-2 Vaccine: Challenges and Prospects
    Mahboob, Tooba
    Ismail, Amni Adilah
    Shah, Muhammad Raza
    Rahmatullah, Mohammed
    Paul, Alok K.
    Pereira, Maria de Lourdes
    Wiart, Christophe
    Wilairatana, Polrat
    Rajagopal, Mogana
    Dolma, Karma G.
    Nissapatorn, Veeranoot
    DISEASES, 2023, 11 (02)
  • [47] Approaches and Challenges in SARS-CoV-2 Vaccine Development
    Dagotto, Gabriel
    Yu, Jingyou
    Barouch, Dan H.
    CELL HOST & MICROBE, 2020, 28 (03) : 364 - 370
  • [48] The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
    Morris, Kevin V.
    MOLECULAR THERAPY, 2020, 28 (07) : 1548 - 1549
  • [49] SARS-CoV-2 Vaccine Development: Current Status
    Poland, Gregory A.
    Ovsyannikova, Inna G.
    Crooke, Stephen N.
    Kennedy, Richard B.
    MAYO CLINIC PROCEEDINGS, 2020, 95 (10) : 2172 - 2188
  • [50] Process development of a SARS-CoV-2 nanoparticle vaccine
    Martinez-Cano, Diandra
    Ravichandran, Rashmi
    Le, Huong
    Wong, H. Edward
    Jagannathan, Bharat
    Liu, Erik J.
    Bailey, William
    Yang, Jane
    Matthies, Kelli
    Barkhordarian, Hedieh
    Shah, Bhavana
    Srinivasan, Nithya
    Zhang, Jun
    Hsu, Angel
    Wypych, Jette
    Stevens, Jennitte
    Piedmonte, Deirdre Murphy
    Miranda, Les P.
    Carter, Lauren
    Murphy, Michael
    King, Neil P.
    Soice, Neil
    PROCESS BIOCHEMISTRY, 2023, 129 : 241 - 256
12345